Sinovac Biotech (SVA) Revenue (2009 - 2024)
Sinovac Biotech (SVA) revenue from Dec 31, 2009 to Dec 31, 2024. The TTM Sinovac Biotech (SVA) revenue is $361M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Sinovac Biotech (SVA) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -23.14% |
| 3 Years | -73.48% |
| 5 Years | +7.99% |
| All Time | +10.20% |
Annual Revenue change of Sinovac Biotech (SVA)
| Year | Revenue | Change |
|---|---|---|
| 2024 | $361M | -23.14% |
| 2023 | $470M | -68.09% |
| 2022 | $1.47B | -92.39% |
| 2021 | $19B | +3692.52% |
| 2020 | $511M | +107.53% |
| 2019 | $246M | +7.14% |
| 2018 | $230M | +31.72% |
| 2017 | $174M | +140.72% |
| 2016 | $72M | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | -100.00% |
| 2011 | $57M | +70.18% |
| 2010 | $33M | -60.33% |
| 2009 | $84M | N/A |
Comparison Sinovac Biotech (SVA) five years revenue CAGR with competitors
Sinovac Biotech (SVA) five years revenue CAGR is 7.99%.